Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy

Forty years into the HIV pandemic, approximately 50% of infected individuals still suffer from a constellation of neurological disorders collectively known as ‘neuroHIV.’ Although combination antiretroviral therapy (cART) has been a tremendous success, in its present form, it cannot eradicate HIV. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Salahuddin, Mohammed F., Qrareya, Alaa N., Mahdi, Fakhri, Moss, Emaya, Akins, Nicholas S., Li, Jing, Le, Hoang V., Paris, Jason J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866218/
https://www.ncbi.nlm.nih.gov/pubmed/34651359
http://dx.doi.org/10.1111/jne.13047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866218/
https://www.ncbi.nlm.nih.gov/pubmed/34651359
http://dx.doi.org/10.1111/jne.13047

Ejemplares similares